Chang Gung University Hospital
Taoyuan, Guishan District, 333, Taiwan
NCT Number: NCT06380478
This is an observational, single-center, non-control, open-label post-marketing study. Patients implanted with an aspicio™ Monofocal Intraocular Lens will be scheduled for a follow-up visit at least 3 months after the surgery to undergo a routine basic ophthalmological examination.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Taoyuan, Guishan District, 333, Taiwan
This is an observational, single-center, non-control, open-label post-marketing study. Patients implanted with an aspicio™ Monofocal Intraocular Lens will be scheduled for a single visit in the facilities of Chang Gung University Hospital at least 3 months after the surgery. Patients will undergo a routine basic ophthalmological examination.
Additionally, and retrospectively, the patients' medical records will be reviewed to obtain information on visual acuity and adverse events at postoperative visit carried out 1 month after surgery.
The data corresponding to the preoperative values of corneal curvature (flat meridian, curved meridian and axes), axial length measured by biometry, visual acuity and those corresponding to the implanted IOL will also be collected from the medical records.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A bi-aspheric monofocal IOL is implanted through preloaded IOL Delivery System in the capsular bag in the posterior chamber of the eye during cataract surgery
Other names: aspicio Monofocal, Asqelio Monofocal, ASPP60Y, ASP60Y, QPIO103Y, QLIO103Y
Time frame: 3 months after implantation
Photopic monocular best corrected distance visual acuity (CDVA), 400cm
Time frame: 3 months after implantation
Photopic monocular defocus curve, -4.0 D ~ +2.0 D
Time frame: 3 months after implantation
Photopic monocular uncorrected distance visual acuity (UDVA), 400cm
Time frame: 3 months after implantation
Photopic monocular uncorrected intermediate visual acuity (UIVA), 60cm
Time frame: 3 months after implantation
Photopic monocular corrected intermediate visual acuity (CIVA), 60cm
Time frame: 3 months after implantation
IOL glistening observation
Time frame: 3 months after implantation
Posterior Capsular Opacification observation
Time frame: 3 months after implantation
Satisfaction questionnaire
Time frame: 3 months after implantation
Signs of inflammation and AEs
ICARES Medicus, Inc.
Industry
Safety and Efficacy of the Bi-Aspheric Monofocal Intraocular Lens
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07735000
Age Related Cataract, Cataract
Peshawar, KPK, Pakistan
View Trial DetailsNCT07605260
Cataract, Eye Diseases
Islamabad, Punjab Province, Pakistan
View Trial DetailsNCT06428955
Cataract, Eye Diseases
Indianapolis, Indiana, United States
View Trial DetailsNCT06111222
Cataract, Eye Diseases
Heidelberg, Germany
View Trial Details